Skip to content
AlternativeMed

Claim Check: "Peptides Are Natural, So They Are Safe"

Claim check on "peptides are natural, so they are safe": why the body making a molecule does not make a product safe, with label, regulator and review evidence.

Content last updated . This page has not been medically reviewed.

The claim

"Peptides are natural, so they are safe" assumes two things: that peptides sold as products are natural, and that natural means safe. Both need checking. A peptide product can be an identical copy of a body molecule, a chemically modified version, a fragment, or a salt in a vial made by a lab. Each of these has its own risks.

What "natural" can mean for a peptide

  • Made by the body (endogenous), such as insulin or GHK, which one review says is present in human blood, saliva and urine. [1]
  • Identical to a human sequence but made by manufacturing, such as human insulin. [2]
  • Modified to last longer, such as semaglutide, which is a GLP-1 analogue with 94% sequence homology, stabilized against the DPP-4 enzyme and bound to albumin. [3][4]
  • A fragment or derivative that the body does not necessarily make as such, such as the seven-amino-acid fragment FDA describes for TB-500. [5]

Calling all four "natural peptides" hides the differences. See natural, synthetic and modified peptides.

Evidence check 1: a body-identical peptide can still harm

The human insulin label states that hypoglycemia is the most common adverse reaction of all insulins, and that severe hypoglycemia can cause seizures, loss of consciousness and death. [2] The molecule is the body's own, yet the product is a high-consequence medicine because the amount, timing and person matter. Label: approved medicine, with serious known risks.

Evidence check 4: compound-by-compound, "natural" has not been enough

  • BPC-157 is described in a review as a naturally occurring gastric peptide, yet FDA found no or only limited safety information for the proposed routes, and a 2025 review found no clinical safety data. [11][7]
  • GHK-Cu occurs in the body, yet FDA states limited human data exist to inform safety for injectable use. [12]
  • TB-500: FDA says potential safety risks in humans are unknown. [5]

"Unknown" is not "safe." A small study without reported adverse events also does not establish safety: a 2026 review of BPC-157 found all three human studies reported no treatment-related adverse events, but rated the certainty of evidence very low. [13]

Where the claim is partly right

Some body-made peptides are well understood, and approved peptide medicines have undergone regulator review. That is a statement about review and evidence for a specific product, not about natural origin.

Verdict

"Peptides are natural, so they are safe" is a marketing claim. Safety depends on the exact molecule, product, quality, route, person and medical context. For symptoms after using any injected product, see when to seek urgent help; for a general framework see peptide safety and adverse events and how to evaluate peptide claims.

Frequently asked questions

Is a peptide the body makes safe to inject?

Not by that fact alone. Human insulin is body-identical and its label warns of severe, sometimes fatal hypoglycemia. [2]

Does "no side effects in a study" mean a peptide is safe?

No. Small, low-quality studies cannot establish safety; reviews rate such evidence very low certainty. [13]

Are approved peptide drugs "unnatural"?

Many are modified versions of body hormones, and they come with regulator-reviewed labels and warnings. [4]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

How to read the evidence labels

Labels used on this page: approved medicine, established, insufficient evidence, marketing claim, evidence of harm, and Proper evidence not found.

Evidence check 2: modified approved peptides carry warnings
Semaglutide and tirzepatide labels carry boxed warnings about thyroid C-cell tumors in rodents, with human relevance not determined. [4][6] Being related to a natural hormone did not remove regulatory safety requirements.
Evidence check 3: product-level risks do not depend on origin
  • FDA says peptides given by injection may pose immunogenicity risk, which can be amplified by aggregation and peptide-related impurities. [7]
  • A review explains that impurities in synthetic peptide products can elicit unwanted immune responses. [8]
  • FDA says compounded drugs are not FDA-approved, so the agency does not review their safety, effectiveness or quality before marketing; contamination or too much active ingredient could cause serious injury or death. [9]
  • Health Canada says unauthorized injectable peptides may contain too much, too little or none of the active ingredient, unlisted ingredients, or contaminants such as bacteria and endotoxins. [10]
References
  1. Pickart L et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int 2015. PubMed. Read 2026-10-22.
  2. Humulin R (insulin human) injection prescribing information, Eli Lilly, DailyMed, U.S. National Library of Medicine. Read 2026-10-22.
  3. Ozempic (semaglutide) injection prescribing information, Novo Nordisk, DailyMed, U.S. National Library of Medicine. Read 2026-10-22.
  4. Wegovy (semaglutide) injection and tablets prescribing information, Novo Nordisk, DailyMed, U.S. National Library of Medicine. Read 2026-10-22.
  5. U.S. Food and Drug Administration. FDA Briefing Document: TB-500-related bulk drug substances, Pharmacy Compounding Advisory Committee, July 23-24, 2026 (document dated 5/15/2026). Read 2026-10-22.
  6. Zepbound (tirzepatide) prescribing information, Eli Lilly, DailyMed, U.S. National Library of Medicine. Read 2026-10-22.
  7. U.S. Food and Drug Administration. FDA Briefing Document: BPC-157-related bulk drug substances, Pharmacy Compounding Advisory Committee, July 23-24, 2026 (document dated 5/11/2026). Read 2026-10-22.
  8. De Groot AS et al. Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discov Today 2023. PubMed. Read 2026-10-22.
  9. U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. Read 2026-10-22.
  10. Health Canada. Think twice before injecting peptides bought online: unauthorized products can seriously harm you (public advisory, last updated 2026-04-09). Read 2026-10-22.
  11. Vasireddi N et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J 2025. PubMed. Read 2026-10-22.
  12. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 04/22/2026). Read 2026-10-22.
  13. Poolton JT et al. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. Acta Orthop Belg 2026. PubMed. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.